Scholarlink

<p>Effective vaccine design ideally elicits potent, durable, and broad-spectrum immunity against rapidly evolving pathogens. However, current platforms, such as recombinant adenovirus vectors and protein nanoparticles, are developed and administered separately, and each has distinct immunological and practical limitations. Here, we introduce a synergistic vaccine framework that intrinsically combines genetic delivery with rational antigen design. We engineer an adenovirus type 5 vector to co-express a prefusion-stabilized SARS-CoV-2 spike and ferritin subunit (Ad5-SpFN), which drives in vivo assembly of spike-decorated nanoparticles. Compared to either platform alone, this unified strategy elicits faster and higher neutralizing antibody titers and robust T-cell responses, and confers complete protection against lethal viral challenge. Mechanistically, Ad5-SpFN enhances early dendritic cell activation and germinal center reactions, leading to a more potent and sustained humoral immune response. Furthermore, it provides exceptional route flexibility, establishing protective mucosal immunity after intranasal administration, which addresses a key limitation of many existing vaccines. This versatile “vector-nanoparticle” hybrid platform can be rapidly reprogrammed, offering a promising strategy for future pandemic preparedness.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Rapid and potent induction of protective mucosal immunity against SARS-CoV-2 by an adenovirus-vectored nanoparticle vaccine

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月27日

查看全文
  • Shixiong Li,
  • Qiong Zi,
  • Junhao Fan,
  • Guangzhen Jiang,
  • Yao Zhang,
  • Danni Feng,
  • Zumrat Nur,
  • Xiaoqing Liu,
  • Jintao Lai,
  • Tao Chen,
  • Xiancai Ma,
  • ZhangYong Hong,
  • Jingyou Yu

摘要

Effective vaccine design ideally elicits potent, durable, and broad-spectrum immunity against rapidly evolving pathogens. However, current platforms, such as recombinant adenovirus vectors and protein nanoparticles, are developed and administered separately, and each has distinct immunological and practical limitations. Here, we introduce a synergistic vaccine framework that intrinsically combines genetic delivery with rational antigen design. We engineer an adenovirus type 5 vector to co-express a prefusion-stabilized SARS-CoV-2 spike and ferritin subunit (Ad5-SpFN), which drives in vivo assembly of spike-decorated nanoparticles. Compared to either platform alone, this unified strategy elicits faster and higher neutralizing antibody titers and robust T-cell responses, and confers complete protection against lethal viral challenge. Mechanistically, Ad5-SpFN enhances early dendritic cell activation and germinal center reactions, leading to a more potent and sustained humoral immune response. Furthermore, it provides exceptional route flexibility, establishing protective mucosal immunity after intranasal administration, which addresses a key limitation of many existing vaccines. This versatile “vector-nanoparticle” hybrid platform can be rapidly reprogrammed, offering a promising strategy for future pandemic preparedness.

Graphical abstract